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Abstract
Background: Low hemoglobin concentration (Hb) and low mean arterial blood
pressure (MAP) impact outcomes in critically ill patients. We utilized an experimental
model of “normotensive” vs. “hypotensive” acute hemodilutional anemia to test
whether optimal tissue perfusion is dependent on both Hb and MAP during acute
blood loss and fluid resuscitation, and to assess the value of direct measurements of
the partial pressure of oxygen in tissue (PtO2).
Methods: Twenty-nine anesthetized rats underwent 40% isovolemic hemodilution
(1:1) (or sham-hemodilution control, n = 4) with either hydroxyethyl starch (HES)
(n = 14, normotensive anemia) or saline (n = 11, hypotensive anemia) to reach a
target Hb value near 70 g/L. The partial pressure of oxygen in the brain and skeletal
muscle tissue (PtO2) were measured by phosphorescence quenching of oxygen using
G4 Oxyphor. Mean arterial pressure (MAP), heart rate, temperature, arterial and venous
co-oximetry, blood gases, and lactate were assessed at baseline and for 60 min after
hemodilution. Cardiac output (CO) was measured at baseline and immediately after
hemodilution. Data were analyzed by repeated measures two-way ANOVA.
Results: Following “normotensive” hemodilution with HES, Hb was reduced to 66 ±
6 g/L, CO increased (p < 0.05), and MAP was maintained. These conditions resulted in a
reduction in brain PtO2 (22.1 ± 5.6 mmHg to 17.5 ± 4.4 mmHg, p < 0.05), unchanged
muscle PO2, and an increase in venous oxygen extraction. Following “hypotensive”
hemodilution with saline, Hb was reduced to 79 ± 5 g/L and both CO and MAP were
decreased (P < 0.05). These conditions resulted in a more severe reduction in brain
PtO2 (23.2 ± 8.2 to 10.7 ± 3.6 mmHg (p < 0.05), a reduction in muscle PtO2 (44.5 ± 11.0 to
19.9 ± 12.4 mmHg, p < 0.05), a further increase in venous oxygen extraction, and a
threefold increase in systemic lactate levels (p < 0.05).
(Continued on next page)
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Conclusions: Acute normotensive anemia (HES hemodilution) was associated with a
subtle decrease in brain tissue PtO2 without clear evidence of global tissue hypoperfusion.
By contrast, acute hypotensive anemia (saline hemodilution) resulted in a profound
decrease in both brain and muscle tissue PtO2 and evidence of inadequate global
perfusion (lactic acidosis). These data emphasize the importance of maintaining CO and
MAP to ensure adequacy of vital organ oxygen delivery during acute anemia. Improved
methods of assessing PtO2 may provide an earlier warning signal of vital organ
hypoperfusion.
Keywords: Hemodilution, Anemia, Mean arterial pressure, Cardiac output, Hypotension,
Partial pressure of oxygen in tissue
Background
The optimal care of critically ill patients often involves management of multiple risk
factors for inadequate organ perfusion, including hypotension and anemia. Assessment
of the impact of hypotension and anemia in the perioperative period demonstrates that
both factors are associated with serious adverse outcomes. Interoperative hypotension
has been associated with increased brain [1, 2], heart [3–5], and kidney injury [3, 6, 7]
and mortality [8–10]. These outcomes often depend on the magnitude and duration of
hypotension; for example, a 40% drop in mean arterial pressure (MAP) from baseline
for more than 30 min has been associated with myocardial injury [5]. Perioperative and
acute interoperative anemia have also been associated with similar patterns of adverse
events; including evidence of brain [11, 12], heart [13, 14], and kidney injury [15, 16]
and mortality [14, 16–18]. Experimental models of acute anemia suggest that inadequate
microcirculatory perfusion and tissue hypoxia contribute as a mechanism of vital organ
injury and mortality [19–21].
Additionally, current clinical practice often favors a restrictive fluid therapy and red
blood cell (RBC) transfusion approaches in surgical and critically ill patients. While
many of the completed prospective randomized clinical trials favor the non-inferiority of
a restrictive transfusion threshold near a hemoglobin concentration (Hb) of 70–80 g/L
[22–24], more recent analysis of these data suggest that low Hb levels in the restrictive
arms of these studies may be associated with increased organ injury and mortality in
specific patient populations [25, 26].
We performed an experimental study to measure the partial pressure of oxygen in
tissue (PtO2) in the brain and skeletal muscle, and other parameters of systemic
perfusion, under conditions of acute normotensive vs. hypotensive hemodilutional
anemia to assess the combined impact of acute anemia and hypotension on tissue per-
fusion. We hypothesize that optimal tissue perfusion depends on multiple interactive




The Animal Care and Use Committee at St. Michael’s hospital approved all animal
protocols. Twenty-nine male Sprague-Dawley rats (Jackson laboratory) with a mean
weight near 500 g were anesthetized with isoflurane 2–3% in 21% oxygen for the
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duration of the experiment. The trachea was intubated and the lungs were mechanic-
ally ventilated using a pressure controlled ventilator, with peak inspiratory pressure be-
tween 15 and 17 cm H2O and a respiratory rate between 60 and 70 breaths per minute
and no additional PEEP, to a target partial pressure of arterial carbon dioxide (PaCO2)
near 40 mmHg (Kent Scientific Corp., Torrington, CT 06790).
The tail artery and vein were cannulated to perform the hemodilution and to monitor
MAP, arterial blood gases, and Hb by co-oximetry. A jugular venous catheter was
inserted in a retrograde manner toward the right atrium to provide measurements of
venous blood gases. Ventilation was monitored by arterial blood gases to maintain
normoxia and normocapnia. Blood pressure, ECG, and body temperature were
measured using a computerized data-acquisition system (PowerLab, ADInstruments
Inc., Colorado Springs CO 80906). Rectal temperature was maintained between 35 and
36 °C using a heating plate. The partial pressure of oxygen in the tissue (brain, skeletal
muscle) or PtO2 was measured using oxygen-dependent quenching of phosphorescence
as previously described [27] utilizing a novel microsensor G4 Oxyphor technology
(PMOD1000 instrument, Oxygen Enterprises, Ltd., Philadelphia, PA 19104–1808).
Hemodilution protocol
After performing all of the procedures, baseline measurements were collected for
10 min. Rats then underwent either “normotensive” hemodilution with 1:1 volume
exchange of 40% estimated total blood volume (30 ml/kg) with either 6% hydroxyethyl
starch (HES) 130/0.4 in 0.9% sodium chloride (Voluven, n = 14, Fresenius Kabi Canada,
Mississauga ON L4W 4Y3), or “hypotensive” hemodilution with 0.9% sodium chloride
(saline, n = 11). During hemodilution, arterial blood was exchanged with HES or saline
at a fixed rate over 10 min, using the push-pull infusion pump (PHD2000, Harvard
Apparatus Canada, St. Laurent, Quebec, H4S 1R9). Following hemodilution, physio-
logic parameters were continuously acquired during a 60-min recovery period. Brain
and hind limb skeletal muscle tissue PtO2 were recorded continuously. Arterial and
venous blood gases and co-oximetry measurements were collected at baseline, immedi-
ately following hemodilution, and at 30 and 60 min following completion of hemodilu-
tion using a heparinized syringe. Samples were analyzed using a blood gas analyzer and
co-oximeter (ABL 800, Radiometer Canada, London ON, N5V 4T7).
An additional four rats were placed in a sham control group and did not undergo
hemodilution, to serve as a time-based negative control group.
Cardiac output measurements
These experiments included four rats per hemodilution group, which underwent
cardiac output (CO) measurements before and after hemodilution. Transthoracic
echocardiography was performed in hemodiluted rats in the supine position at baseline
and within 15 to 30 min following hemodilution utilizing a high-frequency ultrasound
system (Vevo 2100, MS-250 transducer, Visualsonics, Toronto, ON). Two dimensional
long-axis images of the left ventricle in parasternal long- and short-axis views with
M-mode measurements at mid-papillary muscle level and linear dimensions were
analyzed offline (Vevo 2100 software v. 1.3) using the standard leading edge to
leading edge technique. CO was calculated as SV × HR, where SV and HR are
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stroke volume and heart rate, respectively. SV and ejection fraction (EF) were mea-
sured using the Teicholz cubed formula, LV volume = 7 × LVID3/(2.4 + LVID),
followed by the difference between ESV and EDV, where LVID, ESV, and EDV are
left ventricular internal diameter, end systolic volume, and end diastolic volume,
respectively. Fractional shortening (FS%) was calculated as (LVIDd − LVIDs)/
LVIDd × 100, where LVIDd and LVIDs are left ventricular end diastolic and end
systolic internal diameters, respectively. Three consecutive cardiac cycles were
averaged for all analyses.
Statistical analysis
All data are presented as mean ± SD. Data were analyzed by repeated measures
two-way ANOVA and post hoc Tukey test, where appropriate according to Sigmaplot
software (SigmaStat 11.0).
Results
Baseline values were comparable for all parameters measured between the three experi-
mental and control groups. No differences in heart rate (299.0 ± 29.5, 309.7 ± 51.8, 290.5
± 3.2 bpm) or body temperature (36.1 ± 0.5, 36.0 ± 0.4, 35.9 ± 0.3 °C) were observed at
baseline or at any time point for the HES, saline, and sham control groups, respectively.
Arterial and venous blood gases and Hb concentrations are reported in Tables 1 and 2.
Arterial and venous co-oximetry and blood gas analysis
In the normotensive hemodilution (HES) group, mean Hb values decreased from a
baseline of 131 ± 9 to 66 ± 6 g/L immediately following hemodilution (p < 0.001). In the
hypotensive hemodilution saline group, Hb decreased from 130 ± 11 to 79 ± 5 g/L
(Table 1; p < 0.001). The Hb concentration in the saline hemodilution group was
initially higher than in the HES hemodilution group (Table 1). In the sham control rats,
Hb did not decrease over time.
Arterial oxygen tension (PaO2) and Hb saturation remained stable and did not
decrease throughout the experimental protocol in any group (Tables 1 and 2, Fig. 1).
Venous oxygen tension (PvO2) and saturation decreased from baseline after 60 min in
all groups. There was no difference between PvO2 between the sham controls and the
HES hemodilution group. By contrast, there was a more profound decrease in PvO2
and saturation in the saline hemodiluted group (Tables 1 and 2, Fig. 1, p < 0.05).
Following saline hemodilution, the PaO2 was increased transiently at 30 min following
hemodilution. This change was associated with a reduction in PaCO2 (Table 2; p < 0.001),
which is consistent with a respiratory compensation to metabolic acidosis. Animals in this
group developed a lactic acidosis, as indicated by a significant increase in lactate, a reduc-
tion in pH, and HCO3
− (Table 2, Fig. 1, p < 0.001 for all). A maximal rise in arterial lactate
was achieved by 60 min following hemodilution (3.5 ± 1.3 to 10.9 ± 6.2 mmol/L, p < 0.05).
Mean arterial blood pressure measurements
There was a significant treatment, time, and interaction effect (two-way ANOVA;
p < 0.001 for all). MAP was maintained for the duration of the 60-min recovery period
in both the normotensive hemodilution and control group (Fig. 2). By contrast, there was
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Fig. 1 (See legend on next page.)
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an immediate decrease in MAP following hemodilution in the saline hemodilution group
(77.3 ± 4.0 vs. 42.8 ± 5.2 mmHg, p < 0.05), which persisted to the 60-min recovery period
(31.1 ± 12.8 mmHg). MAP was significantly lower in the saline hemodilution group,
relative to both controls and starch hemodilution groups at all post-hemodilution time
points (Fig. 2, p < 0.001).
Partial pressure of oxygen in brain and muscle tissue (PtO2)
There was a significant time and interaction effect for brain PtO2 when comparing all
three experimental groups (two-way ANOVA; p < 0.001 for both). Brain PtO2 remained
stable in the time-based control sham hemodiluted group. Following normotensive he-
modilution with HES, brain PtO was reduced from a baseline value of 22.1 ± 5.6 mmHg
to a value of 15.6 ± 6.5 mmHg immediately following hemodilution. The brain PtO2
remained decreased for 60 min reaching a value of 17.5 ± 4.4 mmHg (Fig. 2, p < 0.05).
Rats undergoing hypotensive hemodilution with saline experienced a greater decrease
in brain PtO2 which decreased from baseline (23.2 ± 8.2 mmHg) to values as low as
16.0 ± 4.5 mmHg immediately following hemodilution. The brain PtO2 reached a nadir
value of 10.7 ± 3.6 mmHg after 60 min (Fig. 2, p < 0.05).
There was no time or interaction effect observed for hind limb skeletal muscle PO2
(p = 0.051 and 0.082, respectively). However, there was a significant time-treatment
interaction (two-way ANOVA; p < 0.001). No change in muscle PtO2 was observed fol-
lowing sham procedure or HES hemodilution (Fig. 2). By contrast, muscle PO2 de-
creased significantly from baseline values of 44.5 ± 11.0 mmHg to 30.6 ± 10.6 mmHg
immediately following hemodilution with saline (Fig. 2, p < 0.05). In this group, muscle
PtO2 reached a nadir at 60 min (19.9 ± 12.4 mmHg, p < 0.05).
Cardiac output measurements
CO data from normotensive and hypotensive hemodilution groups are presented in
Table 3. These experiments demonstrate that CO is increased in the normotensive HES
hemodilution group, predominantly due to an increase in diastolic volume and stroke
volume. These changes were not observed in the hypotensive saline hemodilution
group which demonstrated a decrease in CO, SV, and diastolic volume (Table 3).
Discussion
We demonstrated a significant interaction between low Hb concentration and low
MAP with respect to limiting tissue oxygen delivery in brain and muscle, in a model of
normotensive vs. hypotensive hemodilution. During normotensive hemodilution with
HES, blood pressure was maintained, CO increased, and systemic perfusion was
(See figure on previous page.)
Fig. 1 Upper panel Arterial PO2 remained stable except for a transient increase at 30 min (associated with
hyperventilation) in the saline hemodilution group. A significant reduction in venous PO2 was observed in
the saline hemodilution group relative to the controls (*p < 0.001 vs. baseline, #p < 0.05 vs. control). Middle
panel Arterial oxygen saturation remained stable in all groups. A significant reduction in venous PO2 was
observed in all groups relative to baseline. The venous oxygen saturation in the saline hemodilution group
was reduced relative to the controls and HES group (*p < 0.001 vs. baseline, #p < 0.05 vs. control and HES).
Lower panel A significant rise in arterial lactate was only observed in the saline hemodilution group (*p < 0.001
vs. baseline, #p < 0.05 vs. control and HES)
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Fig. 2 (See legend on next page.)
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generally preserved, as indicated by the absence of lactic acidosis and sustained muscle
PtO2. However, under these conditions, brain tissue PtO2 was significantly reduced,
suggesting that tissue oxygen delivery did not meet the higher metabolic requirements
for oxygen in the brain. These data are consistent with our previous studies, which
demonstrate that acute normotensive anemia is associated with brain tissue hypoxia
and activation of hypoxic cellular signaling pathways, including hypoxia inducible
factor (HIF) [20]. This data may help to explain why acute hemodilution and anemia
are associated with increased stroke incidence in patients undergoing cardiac and non-
cardiac surgery [11, 12]. In addition, acute anemic conditions which produce mild brain
tissue hypoxia have been associated with evidence of more severe renal tissue hypoxia
[21, 28]; providing a plausible explanation for both stroke acute kidney injury (AKI) in
patient exposed to hemodilutional anemia [12, 16]. The combined effect of inadequate
perfusion to vital organs during acute anemia may contribute to the observed associ-
ation of increased mortality in anemic perioperative patients [16, 17].
By contrast, hemodilution with saline resulted in hypotension, a reduction in CO, a
further reduction in brain PtO2, a newly observed reduction in muscle PtO2, and a
(See figure on previous page.)
Fig. 2 Upper panel Mean arterial pressure remained stable in controls and after hemodilution with
hydroxyethyl starch (HES) but decreased significantly, relative to controls and HES hemodilution groups,
following hemodilution with saline (*p < 0.001 vs. baseline, #p < 0.05 vs. control and HES). Middle panel Brain
PO2 decreased from baseline following hemodilution with both HES and saline (*p < 0.001 vs. baseline).
Lower panel Skeletal muscle PO2 remained stable in control and HES hemodilution groups but was reduced
relative to baseline and controls after saline hemodilution (*p < 0.001 vs. baseline, #p < 0.05 vs. control
and HES)
Table 3 ECHO measures following hemodilution
Baseline Post-hemodilution
MAP (mmHg) HES 82.2 ± 19.6 74.3 ± 19.7
Saline 103.6 ± 12.6 60.0 ± 5*
Hb (g/L) HES 144 ± 6 77 ± 7*
Saline 136 ± 3 88 ± 10*#
CO (mL/min) HES 57.7 ± 8.7 116.8 ± 15.6*
Saline 72.8 ± 22.4 41.1 ± 14.0*#
HR (bpm) HES 323.6 ± 46.1 382.0 ± 29.0
Saline 362.9 ± 22.7 333.0 ± 23.0
SV (μL) HES 179.9 ± 26.9 305.7 ± 32.2*
Saline 199.1 ± 55.5 122.1 ± 33.8*#
Diastole volume (μL) HES 217.5 ± 45.1 331.8 ± 30.8*
Saline 263.5 ± 70.2 149.8 ± 33.1*#
Systole volume (μL) HES 37.6 ± 21.9 26.1 ± 12.1
Saline 64.4 ± 16.6 27.7 ± 11.2
EF (%) HES 83.5 ± 6.6 92.1 ± 3.6
Saline 75.3 ± 2.8 81.1 ± 8.7
FS (%) HES 54.2 ± 7.4 66.8 ± 6.6
Saline 45.4 ± 2.8 51.1 ± 8.7
*p < 0.01 vs. baseline, #p < 0.05 vs HES; two-way ANOVA repeated measures
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severe increase in lactate suggestive of profound systemic ischemia. These data demon-
strate the additive impact of combined low Hb in the face of a low CO and low MAP
on tissue oxygen delivery in an experimental model. The mechanism likely involves
inadequate fluid resuscitation with reduced intravascular volume and an inadequate
cardiovascular response to anemia as indicated by the CO and diastolic volume
analysis. From prior studies, we understand that during acute anemia, oxygen homeostasis
is maintained by an active increase in CO to ensure perfusion of vital organs including
the brain [19, 20]. Inhibition of the CO response results in accentuation of tissue hypoxia
[19]. We observed a similar effect in the saline hemodilution group where an inadequate
CO response to anemia resulted in profound tissue hypoxia further demonstrating the
need to preserve adequate intravascular fluid volume during anemia.
Can measurement of tissue PO2 inform clinical practice to improve outcomes?
Clinical monitoring of the partial pressure of oxygen in brain tissue has been performed
directly using invasive tissue probes in patients exposed to neurotrauma; however, the in-
vasive nature of these probes severely limits their use clinically. Indirect assessment of
brain PtO2 has been achieved utilizing near infrared spectroscopy (NIRS). NIRS measures
changes in arterial and venous oxy- and deoxyhemoglobin levels which indirectly reflect
levels of microvascular oxygenation. NIRS is capable of detecting cerebral microvascular
oxygen desaturation in patients undergoing heart surgery [6, 29–31]. Treatment algo-
rithms have been defined to respond to, and correct, episodes of cerebral desaturation
[29, 31]. While these maneuvers are able to correct the observed cerebral desaturations,
only one study has demonstrated improvement in patient outcome [31].
Other novel light-based methods for directly measuring cellular energetics and tissue
PO2 are being developed. Spectroscopic approaches, including broadband spectroscopy,
allowed for measurement of the oxidative state of cellular cytochromes which reflect
cellular energetics [32, 33]. Measurement of cutaneous mitochondrial PO2, utilizing the
oxygen-dependent delayed fluorescence of protopor-phyrin IX in the skin [34, 35], has
been used to assess the mitochondrial PO2 response to acute hemodilution in an ex-
perimental pig model [35]. This approach was able to detect tissue hypoxia at an earlier
stage of hemodilution relative to more traditional measurements including changes in
MAP, serum lactate, VO2, and NIRS [35]. Future studies will be required to assess the
impact of these technologies on patient outcomes.
In clinical studies, both hypotension [1–10] and anemia [11–18] have been indepen-
dently associated with increase acute renal injury [3, 6, 7, 15, 16], myocardial infarction
[3–5, 13, 14], stroke [1, 2, 11, 12], and mortality [8–10, 14, 16–18]. However, few of these
retrospective analyses have formally assessed the combined impact of low Hb and low
MAP on patient outcome. A 2012 post hoc analysis by Haase et al. demonstrated a 3.36
(1.34–8.41)-fold increase in cardiac surgery risk of AKI associated with a combination of
anemia and hypotension during CPB relative to anemia alone [36]. However, a retrospect-
ive study by Sickeler et al. in 2014, which intended to replicate Haase’s findings, involved
a much larger cohort of 3963 patients and did not find any association between the co-
occurrence of hypotension and anemia in cardiac surgery-related AKI risk [37]. Further
clinical research is needed to fully assess the potential interaction between anemia and
hypotension and their combined impact on patient outcome.
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Optimal choice of resuscitation fluid in critical care
Data to support the choice of optimal fluid for resuscitation (blood, colloid, crystalloid,
blood substitute) in specific critical care settings is lacking [38]. While a complete review
is beyond the scope of this manuscript, our data support some interesting observations
about fluid restriction and the potential value of monitoring tissue PtO2 to assess fluid
replacement and transfusion strategies. Recent assessment of clinical practice favors
goal-directed and/or restrictive fluid management strategies [39]. In addition, review of
management strategies in critical care demonstrate a preference toward crystalloid as the
first choice for fluid therapy [40] and an overall increase in vasopressor use [41]. This
combination of treatment strategies may lead to an increased risk of patients with reduced
intravascular volume and support the priority of increased utilization of monitors which
assess the adequacy of microvascular perfusion of vital organs [42].
Data from prospective randomized trials assessing restrictive vs. liberal RBC transfusion
thresholds have largely favored a restrictive approach [43]. More recent analysis suggest
that some patient populations may be harmed by this restrictive approach including
patients undergoing cardiac surgery [44, 45] or those experiencing acute myocardial
ischemia [25]. Data from the TITRe2 trial demonstrated that patients randomized to a
restrictive transfusion threshold (Hb <7.5 g/dL) experienced a higher mortality [(4.2 vs.
2.6%; HR 1.64 (1.00 to 2.679)], relative to patients randomized to a liberal threshold [44].
Early data from the TRICS trial in cardiac surgery also demonstrated a trend to increased
adverse events including stroke (3 vs. 0) and death (4 vs. 1) in the restrictive study arm
[46]. Utilization of methods to directly assess tissue oxygen delivery may help to define
appropriate patient-specific fluid therapy and RBC transfusion thresholds in different
patient populations. Finally, direct measurement of tissue oxygen delivery may promote
the development of novel blood substitutes, including hemoglobin-based oxygen carriers
(HBOCs). In experimental models, HBOCs have been demonstrated to maintain oxygen
delivery to tissue during severe degrees of volume exchange [47]. However, due to con-
cerns about toxicity and adverse clinical outcomes associated with HBOC use [48], future
development of HBOCs will require measures of both efficacy (PtO2) and safety.
There are several limitations to the current study. We did not provide a whole blood
exchange control, as these controls had been performed previously without any effect
on tissue oxygen measurements relative to time-based controls [49]. We did not
directly assess changes in intravascular volume. Further, although crystalloids and col-
loids are used clinically, they are typically not used comparably in a direct 1:1 blood
volume exchange. Thus, our saline hemodilution group likely resulted in additional
hemodynamic stress, including reduced intravascular volume that is not reflective of
clinical care.
Conclusions
In this study, we observed that hypotensive anemia (1:1 saline/blood fluid exchange)
resulted in global ischemia and severe tissue hypoxia. By contrast, normotensive anemia
(1:1 HES/blood fluid exchange) preserved global organ perfusion but was unable to
prevent a subtle reduction in brain tissue PtO2. These data support the ongoing assess-
ment of clinically applicable technologies to assess and measure tissue PtO2, in order to
develop strategies maintaining tissue oxygen delivery and limiting adverse events
associated with tissue hypoxia in patients with critical illness.
Kei et al. Intensive Care Medicine Experimental  (2017) 5:12 Page 12 of 15
Abbreviations
Hb: Hemoglobin; HES: Hydroxyethyl starch; MAP: Mean arterial pressure; PCO2: Partial pressure of carbon dioxide;
PO2: Partial pressure of oxygen
Funding
This study was supported by the Children’s Discovery Institute and St. Michael’s Hospital AHSC AFP Innovation Fund.
Dr. Hare and Dr. Mazer are supported by University of Toronto, Department of Anesthesia Merit Awards.
Availability of data and materials
The datasets supporting the conclusions of this article are included within the article and its additional files.
Authors’ contributions
GMTH, CDM, AD, SR, DFW, and AKYT conceptualized the study and designed the protocol. AKYT, NM, TK, EL, and JFD
performed the experiments. GMTH, CDM, TK, NM, and AKYT analyzed the data and performed the statistical analysis.
GMTH, CDM, AD, TK, NM, SR, DFW, and KC wrote and edited the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Ethics approval
All animal protocols were approved by the Animal Care and Use Committee at St. Michael’s Hospital.
Author details
1Department of Anesthesia, St. Michael’s Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada. 2Keenan
Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 30 Bond Street,
Toronto, Ontario M5B 1W8, Canada. 3Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8,
Canada. 4Division of Pediatric Critical Care Medicine, Washington University in Saint Louis, Saint Louis, MO 63130, USA.
5Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
19104, USA. 6Department of Medicine, Division of Cardiology, St. Michael’s Hospital, 30 Bond Street, Toronto, Ontario
M5B 1W8, Canada.
Received: 9 September 2016 Accepted: 21 February 2017
References
1. Bijker JB, Persoon S, Peelen LM, Moons KG, Kalkman CJ, Kappelle LJ, van Klei WA (2012) Intraoperative hypotension
and perioperative ischemic stroke after general surgery: a nested case-control study. Anesthesiology 116(3):658–664
2. Group PS, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L et al
(2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a
randomised controlled trial. Lancet 371(9627):1839–1847
3. Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI (2013)
Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery:
toward an empirical definition of hypotension. Anesthesiology 119(3):507–515
4. Devereaux PJ, Sessler DI, Leslie K, Kurz A, Mrkobrada M, Alonso-Coello P, Villar JC, Sigamani A, Biccard BM, Meyhoff
CS et al (2014) Clonidine in patients undergoing noncardiac surgery. N Engl J Med 370(16):1504–1513
5. van Waes JA, van Klei WA, Wijeysundera DN, van Wolfswinkel L, Lindsay TF, Beattie WS (2016) Association
between intraoperative hypotension and myocardial injury after vascular surgery. Anesthesiology 124(1):35–44
6. Ono M, Arnaoutakis GJ, Fine DM, Brady K, Easley RB, Zheng Y, Brown C, Katz NM, Grams ME, Hogue CW (2013)
Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with
acute kidney injury. Crit Care Med 41(2):464–471
7. Sun LY, Wijeysundera DN, Tait GA, Beattie WS (2015) Association of intraoperative hypotension with acute kidney
injury after elective noncardiac surgery. Anesthesiology 123(3):515–523
8. Bijker JB, van Klei WA, Vergouwe Y, Eleveld DJ, van Wolfswinkel L, Moons KG, Kalkman CJ (2009) Intraoperative
hypotension and 1-year mortality after noncardiac surgery. Anesthesiology 111(6):1217–1226
9. Monk TG, Bronsert MR, Henderson WG, Mangione MP, Sum-Ping ST, Bentt DR, Nguyen JD, Richman JS, Meguid
RA, Hammermeister KE (2015) Association between intraoperative hypotension and hypertension and 30-day
postoperative mortality in noncardiac surgery. Anesthesiology 123(2):307–319
10. Sessler DI, Sigl JC, Kelley SD, Chamoun NG, Manberg PJ, Saager L, Kurz A, Greenwald S (2012) Hospital stay and
mortality are increased in patients having a “triple low” of low blood pressure, low bispectral index, and low
minimum alveolar concentration of volatile anesthesia. Anesthesiology 116(6):1195–1203
11. Ashes C, Judelman S, Wijeysundera DN, Tait G, Mazer CD, Hare GM, Beattie WS (2013) Selective beta1-antagonism
with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort
study of 44,092 consecutive patients. Anesthesiology 119(4):777–787
12. Karkouti K, Djaiani G, Borger MA, Beattie WS, Fedorko L, Wijeysundera D, Ivanov J, Karski J (2005) Low hematocrit
during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann
Thorac Surg 80(4):1381–1387
13. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G, Mitsakakis N, Hare GM (2010) Acute surgical anemia
influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study.
Anesthesiology 112(1):25–33
Kei et al. Intensive Care Medicine Experimental  (2017) 5:12 Page 13 of 15
14. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, Sharma SC, Vezeridis M, Khuri SF, Friedmann
PD (2007) Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac
surgery. JAMA 297(22):2481–2488
15. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanov J, Karski J, David TE (2005)
Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac
surgery. J Thorac Cardiovasc Surg 129(2):391–400
16. Loor G, Li L, Sabik JF 3rd, Rajeswaran J, Blackstone EH, Koch C (2012) Nadir hematocrit during cardiopulmonary
bypass: end-organ dysfunction and mortality. J Thorac Cardiovasc Surg 144(3):654–662.e654
17. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir
PM et al (2011) Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort
study. Lancet 378(9800):1396–1407
18. Carson JL, Poses RM, Spence RK, Bonavita G (1988) Severity of anaemia and operative mortality and morbidity.
Lancet 1(8588):727–729
19. Hu T, Beattie WS, Mazer CD, Leong-Poi H, Fujii H, Wilson DF, Tsui AK, Liu E, Muhammad M, Baker AJ et al (2013)
Treatment with a highly selective beta(1) antagonist causes dose-dependent impairment of cerebral perfusion
after hemodilution in rats. Anesth Analg 116(3):649–662
20. Tsui AK, Marsden PA, Mazer CD, Adamson SL, Henkelman RM, Ho JJ, Wilson DF, Heximer SP, Connelly KA, Bolz SS
et al (2011) Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive
responses to severe anemia. Proc Natl Acad Sci U S A 108(42):17544–17549
21. Tsui AK, Marsden PA, Mazer CD, Sled JG, Lee KM, Henkelman RM, Cahill LS, Zhou YQ, Chan N, Liu E et al (2014)
Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue
hypoxia. Am J Physiol Regul Integr Comp Physiol 307(1):R13–R25
22. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K
et al (2011) Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365(26):2453–2462
23. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH
et al (2010) Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.
JAMA 304(14):1559–1567
24. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A
multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion
Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409–417
25. Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, Srinivas V, Menegus MA, Marroquin OC, Rao SV
et al (2013) Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease.
Am Heart J 165(6):964–971.e961
26. Hovaguimian F, Myles PS (2016) Restrictive versus liberal transfusion strategy in the perioperative and acute care
settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology
125(1):46–61
27. Yu J, Ramadeen A, Tsui AK, Hu X, Zou L, Wilson DF, Esipova TV, Vinogradov SA, Leong-Poi H, Zamiri N et al (2013)
Quantitative assessment of brain microvascular and tissue oxygenation during cardiac arrest and resuscitation in
pigs. Anaesthesia 68(7):723–735
28. van Bommel J, Siegemund M, Henny C, Ince C (2008) Heart, kidney, and intestine have different tolerances for
anemia. Transl Res 151(2):110–117
29. Deschamps A, Hall R, Grocott H, Mazer CD, Choi PT, Turgeon AF, de Medicis E, Bussieres JS, Hudson C, Syed S
et al (2016) Cerebral oximetry monitoring to maintain normal cerebral oxygen saturation during high-risk cardiac
surgery: a randomized controlled feasibility trial. Anesthesiology 124(4):826–836
30. Subramanian B, Nyman C, Fritock M, Klinger RY, Sniecinski R, Roman P, Huffmyer J, Parish M, Yenokyan G, Hogue
CW (2016) A multicenter pilot study assessing regional cerebral oxygen desaturation frequency during
cardiopulmonary bypass and responsiveness to an intervention algorithm. Anesth Analg 122(6):1786–1793
31. Murkin JM, Adams SJ, Novick RJ, Quantz M, Bainbridge D, Iglesias I, Cleland A, Schaefer B, Irwin B, Fox S (2007)
Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth
Analg 104(1):51–58
32. Kolyva C, Ghosh A, Tachtsidis I, Highton D, Smith M, Elwell CE (2013) Dependence on NIRS source-detector spacing of
cytochrome c oxidase response to hypoxia and hypercapnia in the adult brain. Adv Exp Med Biol 789:353–359
33. Yeganeh HZ, Toronov V, Elliott JT, Diop M, Lee TY, St Lawrence K (2012) Broadband continuous-wave technique to
measure baseline values and changes in the tissue chromophore concentrations. Biomed Opt Express 3(11):2761–2770
34. Harms F, Stolker RJ, Mik E (2016) Cutaneous respirometry as novel technique to monitor mitochondrial function: a
feasibility study in healthy volunteers. PLoS One 11(7):e0159544
35. Romers LH, Bakker C, Dollee N, Hoeks SE, Lima A, Raat NJ, Johannes T, Stolker RJ, Mik EG (2016) Cutaneous
mitochondrial PO2, but not tissue oxygen saturation, is an early indicator of the physiologic limit of hemodilution
in the Pig. Anesthesiology 125(1):124–132
36. Haase M, Bellomo R, Story D, Letis A, Klemz K, Matalanis G, Seevanayagam S, Dragun D, Seeliger E, Mertens PR et
al (2012) Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on
post-operative acute kidney injury. Nephrol Dial Transplant 27(1):153–160
37. Sickeler R, Phillips-Bute B, Kertai MD, Schroder J, Mathew JP, Swaminathan M, Stafford-Smith M (2014) The risk of
acute kidney injury with co-occurrence of anemia and hypotension during cardiopulmonary bypass relative to
anemia alone. Ann Thorac Surg 97(3):865–871
38. Orbegozo Cortes D, Gamarano Barros T, Njimi H, Vincent JL (2015) Crystalloids versus colloids: exploring
differences in fluid requirements by systematic review and meta-regression. Anesth Analg 120(2):389–402
39. Corcoran T, Rhodes JE, Clarke S, Myles PS, Ho KM (2012) Perioperative fluid management strategies in major
surgery: a stratified meta-analysis. Anesth Analg 114(3):640–651
40. Miller TE, Bunke M, Nisbet P, Brudney CS (2016) Fluid resuscitation practice patterns in intensive care units of the
USA: a cross-sectional survey of critical care physicians. Perioper Med (London) 5:15
Kei et al. Intensive Care Medicine Experimental  (2017) 5:12 Page 14 of 15
41. Thongprayoon C, Cheungpasitporn W, Harrison AM, Carrera P, Srivali N, Kittamongkolchai W, Erdogan A, Kashani
KB (2016) Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study. BMC
Pharmacol Toxicol 17(1):19
42. Mayer K, Trzeciak S, Puri NK (2016) Assessment of the adequacy of oxygen delivery. Curr Opin Crit Care 22(5):437–443
43. Carson JL, Carless PA, Hebert PC (2013) Outcomes using lower vs higher hemoglobin thresholds for red blood cell
transfusion. JAMA 309(1):83–84
44. Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, Reeves BC (2015) Liberal or restrictive
transfusion after cardiac surgery. N Engl J Med 372(11):997–1008
45. Docherty AB, O'Donnell R, Brunskill S, Trivella M, Doree C, Holst L, Parker M, Gregersen M, Pinheiro de Almeida J,
Walsh TS et al (2016) Effect of restrictive versus liberal transfusion strategies on outcomes in patients with
cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ 352:i1351
46. Shehata N, Burns LA, Nathan H, Hebert P, Hare GM, Fergusson D, Mazer CD (2012) A randomized controlled pilot
study of adherence to transfusion strategies in cardiac surgery. Transfusion 52(1):91–99
47. Hare GM, Liu E, Baker AJ, Mazer CD (2009) Effect of oxygen affinity on systemic perfusion and brain tissue oxygen
tension after extreme hemodilution with hemoglobin-starch conjugates in rats. Intensive Care Med 35(11):1925–1933
48. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (2008) Cell-free hemoglobin-based blood substitutes and risk of
myocardial infarction and death: a meta-analysis. JAMA 299(19):2304–2312
49. McLaren AT, Marsden PA, Mazer CD, Baker AJ, Stewart DJ, Tsui AK, Li X, Yucel Y, Robb M, Boyd SR et al (2007)
Increased expression of HIF-1alpha, nNOS, and VEGF in the cerebral cortex of anemic rats. Am J Physiol Regul
Integr Comp Physiol 292(1):R403–R414
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Kei et al. Intensive Care Medicine Experimental  (2017) 5:12 Page 15 of 15
